We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$551M
AUM Growth
+$101M
Cap. Flow
+$114M
Cap. Flow %
20.73%
Top 10 Hldgs %
5.17%
Holding
1,228
New
467
Increased
212
Reduced
149
Closed
400

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Industrials 14.75%
3 Consumer Discretionary 12.92%
4 Healthcare 11.68%
5 Financials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBH icon
801
Sally Beauty Holdings
SBH
$1.4B
$108K 0.02%
10,371
-12,510
-55% -$160K
RGNX icon
802
Regenxbio
RGNX
$623M
$107K 0.02%
13,784
-656
-5% -$6.16K
CDE icon
803
Coeur Mining
CDE
$15.6B
$106K 0.02%
18,481
+5,813
+46% +$37.7K
YEXT icon
804
Yext
YEXT
$501M
$104K 0.02%
+16,358
New +$119K
BGS icon
805
B&G Foods
BGS
$285M
$103K 0.02%
+14,985
New +$113K
EVGO icon
806
EVgo
EVGO
$200M
$101K 0.02%
+24,880
New +$158K
RUN icon
807
Sunrun
RUN
$2.37B
$99.8K 0.02%
+10,793
New +$134K
UNIT
808
Uniti Group
UNIT
$2.63B
$99.3K 0.02%
+18,052
New +$102K
LXP icon
809
LXP Industrial Trust
LXP
$3.53B
$98.5K 0.02%
2,426
-5,460
-69% -$253K
LGF.B
810
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$96.2K 0.02%
+12,736
New +$89.3K
ALT icon
811
Altimmune
ALT
$539M
$93K 0.02%
+12,905
New +$98.6K
VNDA icon
812
Vanda Pharmaceuticals
VNDA
$312M
$92.2K 0.02%
19,247
-14,199
-42% -$68.2K
LRMR icon
813
Larimar Therapeutics
LRMR
$416M
$92K 0.02%
23,770
+68
+0.3% +$449
FFWM
814
DELISTED
First Foundation Inc
FFWM
$91.3K 0.02%
+14,697
New +$106K
HNST icon
815
The Honest Company
HNST
$417M
$89.3K 0.02%
+12,884
New +$72.9K
VOD icon
816
Vodafone
VOD
$34.9B
$86.4K 0.02%
10,172
-6,757
-40% -$61.5K
IBRX icon
817
ImmunityBio
IBRX
$7.44B
$85.8K 0.02%
+33,504
New +$140K
LXU icon
818
LSB Industries
LXU
$881M
$84K 0.02%
+11,066
New +$95K
OLMA icon
819
Olema Pharmaceuticals
OLMA
$1.02B
$80.3K 0.01%
+13,769
New +$138K
STKL
820
DELISTED
SunOpta
STKL
$79.9K 0.01%
10,379
-5,960
-36% -$42.1K
COGT icon
821
Cogent Biosciences
COGT
$6.79B
$78.8K 0.01%
10,108
-12,570
-55% -$125K
NOVA
822
DELISTED
Sunnova Energy
NOVA
$77.7K 0.01%
+22,666
New +$113K
SGHC icon
823
SGHC Ltd
SGHC
$7.3B
$75.2K 0.01%
+12,064
New +$64.4K
CLVT icon
824
Clarivate
CLVT
$1.3B
$72.1K 0.01%
+14,187
New +$81.7K
FDMT icon
825
4D Molecular Therapeutics
FDMT
$526M
$68.6K 0.01%
+12,309
New +$96.6K

Similar funds

Fox Run Management's Q4 2024 Portfolio in Review

As of Q4 2024, Fox Run Management held 1,228 positions worth $551M, up 23% from $449M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Fox Run Management deployed $114M of net new capital in Q4 2024, opening 467 new positions and adding to 212 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 111,700 shares worth $5.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was BILL Holdings, an estimated $1.94M trimmed.

  • Fox Run Management's largest Q4 2024 buy was State Street Financial Select Sector SPDR ETF: 111,700 shares worth $5.4M.
  • Fox Run Management added most to iShares US Real Estate ETF in Q4 2024, an estimated $3.75M increase.
  • Fox Run Management's biggest Q4 2024 reduction was BILL Holdings, cutting an estimated $1.94M.
  • Fox Run Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $4.21M.
  • Fox Run Management's ten largest holdings make up 5.2% of its $551M portfolio in Q4 2024.
  • Fox Run Management opened 467 new positions and closed 400 in Q4 2024.
  • Fox Run Management's portfolio value rose 23% quarter-over-quarter to $551M.

Based on Fox Run Management's 13F filing for Q4 2024, filed 11 Feb 2025.